105 related articles for article (PubMed ID: 11344094)
21. All-trans retinoic acid regulates CXCL16/SR-PSOX expression.
Wågsäter D; Sheikine Y; Sirsjö A
Int J Mol Med; 2005 Oct; 16(4):661-5. PubMed ID: 16142401
[TBL] [Abstract][Full Text] [Related]
22. Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor gamma, retinoid X receptor alpha, and all-trans retinoic acid than myometrium.
Tsibris JC; Porter KB; Jazayeri A; Tzimas G; Nau H; Huang H; Kuparadze K; Porter GW; O'Brien WF; Spellacy WN
Cancer Res; 1999 Nov; 59(22):5737-44. PubMed ID: 10582693
[TBL] [Abstract][Full Text] [Related]
23. Stimulated release of arachidonic acid by agonists of the peroxisome proliferator-activated receptor and retinoic acid receptors.
Levine L
Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):229-32. PubMed ID: 11728177
[TBL] [Abstract][Full Text] [Related]
24. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.
Haydon RC; Zhou L; Feng T; Breyer B; Cheng H; Jiang W; Ishikawa A; Peabody T; Montag A; Simon MA; He TC
Clin Cancer Res; 2002 May; 8(5):1288-94. PubMed ID: 12006550
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.
Li AC; Brown KK; Silvestre MJ; Willson TM; Palinski W; Glass CK
J Clin Invest; 2000 Aug; 106(4):523-31. PubMed ID: 10953027
[TBL] [Abstract][Full Text] [Related]
26. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice.
Shi W; Haberland ME; Jien ML; Shih DM; Lusis AJ
Circulation; 2000 Jul; 102(1):75-81. PubMed ID: 10880418
[TBL] [Abstract][Full Text] [Related]
27. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
Mehta RG; Williamson E; Patel MK; Koeffler HP
J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
[TBL] [Abstract][Full Text] [Related]
28. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
[TBL] [Abstract][Full Text] [Related]
29. Increased CD36 protein as a response to defective insulin signaling in macrophages.
Liang CP; Han S; Okamoto H; Carnemolla R; Tabas I; Accili D; Tall AR
J Clin Invest; 2004 Mar; 113(5):764-73. PubMed ID: 14991075
[TBL] [Abstract][Full Text] [Related]
30. Activation of peroxisome proliferator-activated receptor gamma and retinoid X receptor results in net depletion of cellular cholesteryl esters in macrophages exposed to oxidized lipoproteins.
Argmann CA; Sawyez CG; McNeil CJ; Hegele RA; Huff MW
Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):475-82. PubMed ID: 12615696
[TBL] [Abstract][Full Text] [Related]
31. Oxysterol and 9-cis-retinoic acid stimulate the group IIA secretory phospholipase A2 gene in rat smooth-muscle cells.
Antonio V; Janvier B; Brouillet A; Andreani M; Raymondjean M
Biochem J; 2003 Dec; 376(Pt 2):351-60. PubMed ID: 12882648
[TBL] [Abstract][Full Text] [Related]
32. Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells.
Chen Q; Ross AC
Exp Cell Res; 2004 Jul; 297(1):68-81. PubMed ID: 15194426
[TBL] [Abstract][Full Text] [Related]
33. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma.
Wang Y; Porter WW; Suh N; Honda T; Gribble GW; Leesnitzer LM; Plunket KD; Mangelsdorf DJ; Blanchard SG; Willson TM; Sporn MB
Mol Endocrinol; 2000 Oct; 14(10):1550-6. PubMed ID: 11043571
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation.
de Dios ST; Bruemmer D; Dilley RJ; Ivey ME; Jennings GL; Law RE; Little PJ
Circulation; 2003 May; 107(20):2548-50. PubMed ID: 12742988
[TBL] [Abstract][Full Text] [Related]
35. Retinoic acid inhibits airway smooth muscle cell migration.
Day RM; Lee YH; Park AM; Suzuki YJ
Am J Respir Cell Mol Biol; 2006 Jun; 34(6):695-703. PubMed ID: 16456186
[TBL] [Abstract][Full Text] [Related]
36. PPARgamma ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-gamma antagonist.
Bishop-Bailey D; Warner TD
FASEB J; 2003 Oct; 17(13):1925-7. PubMed ID: 12897060
[TBL] [Abstract][Full Text] [Related]
37. Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages.
Tang CK; Yi GH; Yang JH; Liu LS; Wang Z; Ruan CG; Yang YZ
Acta Pharmacol Sin; 2004 May; 25(5):581-6. PubMed ID: 15132822
[TBL] [Abstract][Full Text] [Related]
38. Lysophosphatidic acid induces neointima formation through PPARgamma activation.
Zhang C; Baker DL; Yasuda S; Makarova N; Balazs L; Johnson LR; Marathe GK; McIntyre TM; Xu Y; Prestwich GD; Byun HS; Bittman R; Tigyi G
J Exp Med; 2004 Mar; 199(6):763-74. PubMed ID: 15007093
[TBL] [Abstract][Full Text] [Related]
39. Induction of intermediate mesoderm by retinoic acid receptor signaling from differentiating mouse embryonic stem cells.
Oeda S; Hayashi Y; Chan T; Takasato M; Aihara Y; Okabayashi K; Ohnuma K; Asashima M
Int J Dev Biol; 2013; 57(5):383-9. PubMed ID: 23873370
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
